From early minority stakes taken by traditional re/insurers, to outright acquisitions and buyouts by global institutional asset managers, the capital structures of ILS investment managers have ...

KEY TAKEAWAYS Utah sued Kalshi, its affiliates and two Susquehanna trading firms Tuesday, alleging illegal gambling. The ...

Bailey Zimmerman and his chart-toppers “Chevy Silverado” and “Backup Plan,” featuring Luke Combs. Warren was up first to express his gratitude, noting “It takes a village for songwriters to get to the ...

Ed Sheeran spoke on stage about the changes he made to his Loop Tour following the fallout from dropping Macklemore as an opening act. During his Saturday night (September 19) concert in Philadelphia, ...

Nintendo has revealed that a Mario Kart World update will add classic SNES tracks, Knockout Tour courses, and more today. The company announced the news as part of its September 2026 Nintendo Direct ...

With less than two weeks remaining before the regular season opener, the Pittsburgh Steelers find themselves in a high-stakes standoff with star cornerback Joey Porter Jr. While contract disputes are ...

A, B, C and D trains are experiencing disruptions and delays after cracks were found underneath the subway tracks. The MTA announced weekend trackwork had to be extended into Monday so crews could ...

Instrumental and orchestral arrangements with scoring notes for thirty pieces of classical music including Bach, Beethoven ...

See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. What appear to be tire tracks have become visible on the floor of the ...

BM-3103 is a first-in-class topical mTOR inhibitor that promotes autophagy to clear mutant keratin aggregates in epidermolysis bullosa simplex. The Food and Drug Administration (FDA) has granted Fast ...

AKRON, Ohio, June 23, 2026--(BUSINESS WIRE)--BioMendics, LLC, a clinical-stage biotechnology company developing innovative therapies for rare genetic skin disorders, today announced that the U.S. Food ...

Lead candidate BM-3103 (TolaSure® Gel™) now holds Fast Track, Orphan Drug, and Rare Pediatric Disease designations as BioMendics advances the TAMES-02 Phase 2 study (NCT07027345). BioMendics, LLC, a ...